Datum Källa Rubrik Typ Alternativ
2023-07-19 Redeye Redeye: Enzymatica Q2 2023 - Waiting for the cold season Pressreleaser Ladda ner | Visa Stäng
2023-07-18 Penser Access Penser Access: Kommande studieresultat i fokus - Enzymatica Pressreleaser Visa Stäng
2023-07-18 Enzymatica Enzymatica AB: Kvartalsrapport Q2/2023: En spännande och viktig tid framöver Rapporter Ladda ner | Visa Stäng
2023-07-18 Enzymatica Enzymatica AB: Interim report Q2/2023: An exciting and important time ahead Rapporter Ladda ner | Visa Stäng
2023-05-16 Penser Access Penser Access: Interview with Enzymatica - Erik Penser Bank - May 16th 2023 Pressreleaser Visa Stäng
Pressreleaser | 16 May 2023 | Enzymatica

Penser Access: Interview with Enzymatica – Erik Penser Bank – May 16th 2023

Equity analyst Maria Karlsson Osipova interviews Enzymatica’s CEO Claus Egstrand. We get to hear about Claus background and his Enzymatica pitch. Further, they discuss the recently published Q1 report, the ongoing Kent University study with ColdZyme and company’s strategy onward with geographical expansion.

Find the interview on Erik Penser Bank’s YouTube-channel Penser Play: https://youtu.be/7vJAvBV8yMk
This is a press release from Erik Penser Bank. Read more here:  https://epaccess.penser.se/

2023-05-04 Enzymatica Bulletin from Annual General Meeting of Enzymatica AB (publ) Pressreleaser Ladda ner | Visa Stäng
2023-05-04 Enzymatica Kommuniké från årsstämma i Enzymatica AB (publ) Pressreleaser Ladda ner | Visa Stäng
2023-04-28 Penser Access Penser Access: Upp till bevis - Enzymatica Pressreleaser Visa Stäng
2023-04-28 Redeye Redeye: Enzymatica Q1 2023 - A step in the right direction Pressreleaser Ladda ner | Visa Stäng
2023-04-27 Enzymatica Enzymatica AB: Kvartalsrapport Q1/2023: Stark start på året - Enzymaticas tillväxtresa fortsätter enligt plan Rapporter Ladda ner | Visa Stäng
2023-04-27 Enzymatica Enzymatica AB: Interim report Q1/2023: Strong start to the year - Enzymatica's growth journey continues according to plan Rapporter Ladda ner | Visa Stäng
2023-04-05 Enzymatica Enzymatica AB: Enzymatica publishes annual report for 2022 Rapporter Ladda ner | Visa Stäng
2023-04-05 Enzymatica Enzymatica AB: Enzymatica publicerar årsredovisning för 2022 Rapporter Ladda ner | Visa Stäng
2023-03-31 Enzymatica Notice of Annual General Meeting 2023 in Enzymatica AB (publ) Pressreleaser Ladda ner | Visa Stäng
2023-03-31 Enzymatica Kallelse till årsstämma 2023 i Enzymatica AB (publ) Pressreleaser Ladda ner | Visa Stäng
2023-02-20 Penser Access Penser Access: Vår syn på bolagets potential är intakt - Enzymatica Pressreleaser Visa Stäng
2023-02-20 Redeye Redeye: Enzymatica Q4 2022 - Lower than our estimates Pressreleaser Ladda ner | Visa Stäng
2023-02-17 Enzymatica Enzymatica AB: Interim report Q4/2022: A year that laid the foundation for growth Rapporter Ladda ner | Visa Stäng
2023-02-17 Enzymatica Enzymatica AB: Kvartalsrapport Q4/2022: Ett år som lade grunden för tillväxt Rapporter Ladda ner | Visa Stäng
2022-12-06 Redeye Redeye: Redeye Initiates Coverage of Enzymatica Analyser Ladda ner | Visa Stäng
2022-11-16 Enzymatica Enzymatica AB: Enzymatica and University of Kent launch study to explore prevention of upper respiratory virus infections in elite athletes Pressreleaser Ladda ner | Visa Stäng
2022-11-16 Enzymatica Enzymatica AB: Enzymatica och University of Kent startar studie för att undersöka hur elitidrottare kan förebygga virusinfektioner i de övre luftvägarna Pressreleaser Ladda ner | Visa Stäng
2022-11-03 Penser Access Penser Access: Inte helt ute ur coronatunneln - Enzymatica Analyser Visa Stäng
2022-11-02 Enzymatica Enzymatica AB: Kvartalsrapport Q3/2022: En bredare roll för ColdZyme adderar potential för framtiden Rapporter Ladda ner | Visa Stäng
2022-11-02 Enzymatica Enzymatica AB: Interim report Q3/2022: A broader role for ColdZyme adds potential for the future Rapporter Ladda ner | Visa Stäng
2022-11-01 Enzymatica Enzymatica AB: New study confirms ColdZyme stops viruses causing Covid-19 from adhering to human respiratory cells Pressreleaser Ladda ner | Visa Stäng
2022-11-01 Enzymatica Enzymatica AB: Ny studie bekräftar: ColdZyme hindrar virus som orsakar Covid-19 från att fästa vid mänskliga luftvägsceller Pressreleaser Ladda ner | Visa Stäng
2022-08-26 Enzymatica Enzymatica AB: Enzymatica announces outcome of new rights issue Pressreleaser Ladda ner | Visa Stäng
2022-08-26 Enzymatica Enzymatica AB: Enzymatica offentliggör utfall i företrädesemissionen Pressreleaser Ladda ner | Visa Stäng
2022-08-18 Enzymatica Enzymatica AB: Enzymatica publishes supplementary prospectus Pressreleaser Ladda ner | Visa Stäng
2022-08-18 Enzymatica Enzymatica AB: Enzymatica offentliggör tilläggsprospekt Pressreleaser Ladda ner | Visa Stäng
2022-08-16 Enzymatica Enzymatica AB: ColdZyme blockerar även omikronvarianterna BA.4 och BA.5 Pressreleaser Ladda ner | Visa Stäng
2022-08-16 Enzymatica Enzymatica AB: ColdZyme also blocks omicron variants BA.4 and BA.5 Pressreleaser Ladda ner | Visa Stäng

Kommande händelser

25 Apr 2024 | Kvartalsrapport 2024-Q1
7 May 2024 | Årsstämma 2023
8 May 2024 | Årligutdelning
18 Jul 2024 | Kvartalsrapport 2024-Q2
7 Nov 2024 | Kvartalsrapport 2024-Q3
18 Feb 2025 | Bokslutskommuniké 2024